| 产品描述: | USP/UBP 选择性抑制剂;USP/UBP Selective Inhibitors;;InformationGSK2643943A is an inhibitor ofdeubiquitylating enzyme (DUB)with IC50 of 160 nM forUSP20/Ub-Rho.TargetsUSP20/Ub-Rho (Cell-free assay) 160 nM |
| 靶点: |
IC50: 160 nM (USP20/Ub-Rho) |
| 体内研究: |
GSK2643943A (5 mg/kg,ip,每天,持续 6 天) 在 SCC9 肿瘤中增强 oHSV-1 诱导的溶瘤作用。 GSK2643943A (2.5 mg/kg,ip,每天,持续 9 天) 在 SCC7 细胞中的 oHSV-1 T1012G 复制和溶瘤作用中发挥调节作用。 |
| 参考文献: |
1. Nishi Kumari, et al. Targeting the Ubiquitin Proteasome System in Cancer. Shahzad, Hafiz Naveed (2018). Neoplasm Targeting the Ubiquitin Proteasome System in Cancer. , 10.5772/intechopen.69560(Chapter 8).2. Ruitao Lu, et al. USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells. Mol Ther Oncolytics. 2021 Nov 11;23:477-487. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.606 ml |
18.031 ml |
36.062 ml |
| 5 mM |
0.721 ml |
3.606 ml |
7.212 ml |
| 10 mM |
0.361 ml |
1.803 ml |
3.606 ml |
| 50 mM |
0.072 ml |
0.361 ml |
0.721 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |